(Q38995073)

8 September 2017

title

Reduced antibody responses against Plasmodium falciparum vaccine candidate antigens in the presence of Trichuris trichiura (English)

1 reference

8 September 2017

main subject

Plasmodium falciparum

0 references

1 reference

Selidji Todagbe Agnandji

5

object named as

Selidji Todagbe Agnandji

1 reference

8 September 2017

Peter Gottfried Kremsner

14

object named as

Peter G Kremsner

1 reference

8 September 2017

2

Benjamin Mordmüller

1 reference

8 September 2017

13

Maria Yazdanbakhsh

1 reference

8 September 2017

Michael Theisen

9

0 references

Saadou Issifou

12

object named as

Saadou Issifou

1 reference

8 September 2017

11

Ulysse Ateba Ngoa

1 reference

8 September 2017

8

Sina Brückner

1 reference

8 September 2017

1

Meral Esen

1 reference

8 September 2017

author name string

Pablo Martinez de Salazar

3

1 reference

8 September 2017

Ayola Akim Adegnika

4

1 reference

8 September 2017

Frieder Schaumburg

6

1 reference

8 September 2017

Aurore Bouyoukou Hounkpatin

7

1 reference

8 September 2017

Sabine Bélard

10

1 reference

8 September 2017

language of work or name

English

0 references

publication date

18 October 2012

1 reference

8 September 2017

1 reference

8 September 2017

volume

30

1 reference

8 September 2017

issue

52

1 reference

8 September 2017

page(s)

7621-7624

1 reference

Immunization of Saimiri sciureus monkeys with a recombinant hybrid protein derived from the Plasmodium falciparum antigen glutamate-rich protein and merozoite surface protein 3 can induce partial protection with Freund and Montanide ISA720 adjuvants

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.026

Safety and immunogenicity of GMZ2 - a MSP3-GLURP fusion protein malaria vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.026

Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.026

A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.026

Allergy, parasites, and the hygiene hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.026

Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.026

Effect of hookworm infection on wheat challenge in celiac disease--a randomised double-blinded placebo controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.026

Safety of hookworm infection in individuals with measurable airway responsiveness: a randomized placebo-controlled feasibility study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.026

Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.026

Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.026

Cellular and humoral responses to influenza in gabonese children living in rural and semi-urban areas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.026

Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.026

Impairment of tetanus-specific cellular and humoral responses following tetanus vaccination in human lymphatic filariasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.026

Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.026

Cellular and humoral responses to tetanus vaccination in Gabonese children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.026

10.1016/J.VACCINE.2012.10.026

7 January 2021

Identifiers

DOI

1 reference

8 September 2017

1 reference